HOME > ARCHIVE
ARCHIVE
- Sunstar Foundation to Invite Papers on Periodontal Diseases
January 28, 2002
- Gov't Panel to Monitor Life-Science-Related Projects by Different Ministries
January 28, 2002
- Eli Lilly, Vertex Select Candidate for Hepatitis C Treatment
January 28, 2002
- Serious ADR due to Topical Ketoprofen Reported
January 28, 2002
- Sanofi-Synthelabo Transfers Rights for Gabitril to Cephalon
January 28, 2002
- Results of Quality Reevaluation Announced for 20 Ingredients, 2 Formulations
January 28, 2002
- Sankyo Identifies Gene that Regulates Lipid Metabolism
January 28, 2002
- Hayashibara Strives to Be the Only 1 Rather Than No. 1
January 28, 2002
- Revisions of Precautions Required for 26 Ingredients
January 28, 2002
- JFMDA Prepares Guide on Handling of Used Medical Devices
January 28, 2002
- REGULATORY NEWS IN BRIEF
January 28, 2002
- RIKEN Invites Companies to Collaborate in Gene Polymorphism Analysis
January 28, 2002
- Kitasato Univ. Hospital Upgrades Immediate PMS System
January 28, 2002
- NanoCarrier Contracts with GSK for DDS
January 28, 2002
- Tsuruha: Sales Up 19.8%, Profits Up 27% in Semi-annual Results
January 28, 2002
- Theme for 2002 Baelz Prize Decided
January 28, 2002
- Kokuho Chuokai Welcomes On-line Applications for Reimbursement
January 28, 2002
- Switch to Marketing Approval to Increase Efficiency: FPMAJ President
January 28, 2002
- Link Staff Sets Up New Firm to Support Hospitals M&As
January 28, 2002
- REGULATORY NEWS IN BRIEF
January 21, 2002
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
